larotrectinib
bayer
['lung', 'larotrectinib']
#asco22 june 6, 2:11 pm ct, hall d1, poster 12: former lcrf grantee dr. alexander drilon will present a poster session on updated efficacy and safety of larotrectinib in patients with tropomyosin receptor kinase (trk) fusion #lungcancer. 
Working to improve and save lives by funding groundbreaking research for the prevention, diagnosis, treatment and cure of lung cancer.